They will concentrate on the safety of the vaccine and its effectiveness, which has been billed at 95% by Pfizer/BioNTech. Green light: DecemberThe FDA could provide emergency authorization as soon as the first two weeks of December, according to Moncef Slaoui, the chief scientist for "Operation Warp Speed," the US government initiative to develop a Covid-19 vaccine. Children, for example, would not be included because Pfizer has not yet conducted widespread testing of the vaccine among those under the age of 18. Another US government agency, the Centers for Disease Control and Prevention (CDC), would determine the order of priority for distribution of the vaccine. Next vaccines: early 2021The Moderna Covid-19 vaccine could be ready for distribution soon after that of Pfizer/BioNTech and could be followed by February by that of Johnson & Johnson, according to Slaoui, with AstraZeneca/Oxford also expected in the next few months.

Source: Dhaka Tribune November 20, 2020 20:37 UTC